BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 23, 2026
Home » Newsletters » BioWorld

BioWorld

Jan. 9, 1992

View Archived Issues

GENPHARM RAISES $12 MILLION

Read More

COLLAGEN LAWSUIT DROPPED

Read More

MOLECULAR BIO IMAGING AGENT ENTERS PHASE I

Read More

IMRE ARTHRITIS TREATMENT TRIALS APPROVED

Read More

GLYCOMED RECEIVES PATENT NOTICE

Read More

NOVA GETS PATENT FOR LEUMEDIN COMPOUNDS

Read More

SPAIN APPROVES CYTOGEN'S ONCOSCINT

Read More

MGI CONVERTS PREFERRED STOCK

Read More

BIOMIRA STOCK CONTINUES TO RISE

Read More

CALGENE TO GET ANTISENSE PATENT

Read More

IMMUNOMEDICS TO GET BROAD PATENT

Read More

GENSIA, SANDOZ TO PURSUE DIABETES DRUGS

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 22, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 23, 2026
  • Nankai University and Accendatech present new majusculamide D derivatives

    BioWorld Science
    Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
  • Evaxion shares data from characterization of EVX-04

    BioWorld Science
    Evaxion A/S has developed EVX-04, an AI-designed DNA vaccine encoding 1β endogenous retroviruses (ERVs)-derived antigenic fragments to induce broad...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing